Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zacks.com on MSN
48m
NVO's Rybelsus Meets Primary Goal in MACE Study for Diabetes Patients
A late-stage study shows that Novo Nordisk's oral semaglutide, Rybelsus, cuts the risk of MACE by 14% in T2D patients ...
38m
Oxford Medical Products touts positive safety data for ‘mechanical’ weight loss pill
The company is eyeing a pivotal trial for its dual-polymer hydrogel stomach implant following promising first-in-human trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Arrested in trafficking case
Sued by Murdoch’s firms
Crew ID’d in WA jet crash
Chicago named 'rattiest city'
Arizona official pleads guilty
AR marijuana votes blocked
1st trans lawyer at SCOTUS
Copyright infringement suit
Splits with NY magazine
Target to cut prices
$400M aid package for UKR
Washington state shooting
Overseas ballot suits denied
Fuel pump concern recall
Extends student loan pause
China holds live-fire drills
Tests facial recognition tech
FTC bans fake reviews
PA political threat case
Right whale population rises
Meteorite aided early life?
US data protection move
Union opts out of CBA
AU, US $4.7B missile deal
Peru ex-president sentenced
Blinken arrives in Israel
Infant mortality increased
Probing leak of US intel
Raises US growth forecast
Related topics
Rybelsus
Diabetes mellitus type 2
Feedback